Related Experiment Video
Updated: May 10, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors
M Fernández-Ruiz1, A Andrés, F López-Medrano
1Unit of Infectious Diseases, Hospital Universitario "12 de Octubre," Instituto de Investigación Hospital "12 de Octubre" (i+12), School of Medicine, Universidad Complutense, Madrid, Spain. mario_fdezruiz@yahoo.es
Insights
Uncontrolled donation after circulatory death (DCD) kidney transplants (KT) showed lower infection rates despite higher delayed graft function (DGF). These DCD kidney transplant policies are safe, even with antithymocyte globulin (ATG) therapy.
Area of Science:
- Nephrology
- Transplantation immunology
- Infectious disease epidemiology
Background:
- Uncontrolled donation after circulatory death (DCD) kidney transplantation (KT) is associated with increased risks of delayed graft function (DGF) and use of antithymocyte globulin (ATG)-containing therapies, potential risk factors for post-transplant infection.
- Donation after brain death (DBD) serves as a comparator for assessing DCD outcomes.
Purpose of the Study:
- To compare the incidence of infection in kidney transplant recipients from uncontrolled DCD donors versus donation after brain death (DBD) donors.
- To evaluate the safety of uncontrolled DCD kidney transplantation policies concerning post-transplant infection risk.
Main Methods:
- A prospective cohort study included 291 kidney transplant recipients between November 2008 and July 2011.
- Patients were categorized into DCD (n=87) and DBD (n=204) groups, with most DCD donors being uncontrolled Maastricht categories 1 or 2.
- Backward stepwise Cox proportional hazards models were employed to analyze the impact of DCD on infection rates.
Main Results:
- DCD recipients had a lower cumulative incidence of overall, bacterial, cytomegalovirus (CMV), and non-CMV viral infections compared to DBD recipients (P < .05 for all).
- Multivariate analysis revealed DCD was associated with a significantly lower risk of overall infection (hazard ratio: 0.41; P = .012), even with ATG induction.
- No significant difference in overall infection incidence was observed between DCD recipients and age-matched DBD controls (43.7% vs 47.1%, P = .648).
Conclusions:
- Uncontrolled DCD kidney transplantation policies are safe regarding the risk of post-transplant infection.
- Despite higher rates of DGF and the use of ATG-containing therapies, DCD kidney transplantation does not increase infection risk.
Background:
Uncontrolled donations after circulatory death (DCD) present 2 well-established risk factors for infection after kidney transplantation (KT): greater rates of delayed graft function (DGF) and antithymocyte globulin (ATG)-containing sequential therapies.
Methods:
We performed a prospective cohort study of our 291 KT patients between November 2008 and July 2011 to compare the incidences of infection between DCD (n = 87) and donation after brain death (DBD; n = 204) recipients. Most DCD donors were uncontrolled Maastricht categories 1 or 2. Backward stepwise Cox proportional hazards models were used to assess the impact of DCD on the primary study outcome.
Results:
As compared to the DBD group, DCD recipients were younger, less likely to have undergone previous transplantations, exhibited lower dialysis vintage, and displayed a greater incidence of DGF and graft loss, but lower incidence of acute rejection episodes. There were no differences in the non-death-censored graft survival at 2 years (log-rank P = .835). The DCD group showed lower cumulative incidences of overall, bacterial, cytomegalovirus (CMV), and non-CMV viral infections (P < .05 for all). Multivariate analysis, associated DCD with a lower risk of overall infection (hazard ratio: 0.41; 95% confidence interval: 0.28-0.60; P = .012), an effect that remained when the analysis was restricted to patients receiving ATG induction therapy. Finally, there were no differences in the cumulative incidence of overall infection when DCD recipients were compared with age-matched DBD controls: 43.7% vs 47.1% respectively (P = .648).
Conclusion:
Despite the higher rate of DGF and the use of ATG-containing sequential therapy, uncontrolled DCD policies were safe in terms of the risk of post-transplant infection.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

